Valero, Cristina http://orcid.org/0000-0003-3397-2888
Lee, Mark
Hoen, Douglas
Weiss, Kate
Kelly, Daniel W.
Adusumilli, Prasad S. http://orcid.org/0000-0002-1699-2046
Paik, Paul K.
Plitas, George
Ladanyi, Marc
Postow, Michael A.
Ariyan, Charlotte E.
Shoushtari, Alexander N. http://orcid.org/0000-0002-8065-4412
Balachandran, Vinod P. http://orcid.org/0000-0002-2956-223X
Hakimi, A. Ari http://orcid.org/0000-0002-0930-8824
Crago, Aimee M.
Long Roche, Kara C.
Smith, J. Joshua http://orcid.org/0000-0003-2538-5456
Ganly, Ian
Wong, Richard J.
Patel, Snehal G.
Shah, Jatin P. http://orcid.org/0000-0002-6444-6592
Lee, Nancy Y.
Riaz, Nadeem http://orcid.org/0000-0001-9873-5862
Wang, Jingming
Zehir, Ahmet http://orcid.org/0000-0001-5406-4104
Berger, Michael F.
Chan, Timothy A.
Seshan, Venkatraman E. http://orcid.org/0000-0002-9258-2698
Morris, Luc G. T. http://orcid.org/0000-0002-4417-2280
Funding for this research was provided by:
Fundación Alfonso Martín Escudero (N/A)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA205426, R35 CA232097)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 10 July 2020
Accepted: 4 January 2021
First Online: 1 February 2021
Competing interests
: D.H. receives funding from AstraZeneca. M.A.P. reports consulting fees from BMS, Merck, Array BioPharma, Novartis, Incyte, NewLink Genetics, and Aduro, honoraria from BMS and Merck, and research support from RGenix, Infinity, BMS, Merck, Array BioPharma, Novartis, and AstraZeneca. A.N.S. reports advisory board position with BMS, Immunocore, and Castle Biosciences, and institutional research support from BMS, Immunocore, and Xcovery. V.P.B. is a recipient of an immuno-oncology translational research grant from Bristol-Myers Squibb and is an inventor on a patent application related to work on neoantigen modeling. A.M.C. reports advisory board position with Springworks Therapeutics. J.J.S. has received travel support from Intuitive Surgical, Inc. for fellow education and has served as a clinical advisor to Guardant Health, Inc. S.G.P. has a patent PCT/US2016/026717 Methods of Cancer Detection Using PARPI-FL pending, holds equity in Summit Biomedical Imaging, has a patent US 10,016,238B2 Apparatus, system and method for providing laser steering and focusing for incision, excision, and ablation of tissue in minimally invasive surgery, and holds equity in ColdSteel Laser, Inc. N.R. reports research support from Pfizer and BMS, and consulting fees from REPARE Therapeutics, Mirati Therapeutics, and Illumina. A.Z. reports honoraria from Illumina. T.A.C. acknowledges grant funding from Bristol-Myers Squibb, AstraZeneca, Illumina, Pfizer, An2H, and Eisai, has served as an advisor for Bristol-Myers Squibb, Illumina, Eisai, and An2H, holds equity in An2H, and is a co-founder of Gritstone Oncology and holds equity. T.A.C. and L.G.T.M. are inventors on a patent held by Memorial Sloan Kettering related to the use of TMB in cancer immunotherapy. L.G.T.M. reports laboratory research funding from AstraZeneca. All remaining authors have declared no conflicts of interest.